FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/14/2026
Back to search
Official data from USPTO
PATHIOS THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PATHIOS THERAPEUTICS
ST13
US500000079421902Class
5, 42
Filing
79421902
Registration
8208841
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
07/14/2026
Trademark type
Word
Nice classes
5, 42
Filing date
02/25/2025
Registration date
04/14/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/14/2026
Last transaction
07/14/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
PARKS, KIMBERLY L
Law office
M30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Pathios Therapeutics Limited
Representatives
Jeffrey A. Smith Millen, White, Zelano & Branigan, P.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals for the treatment of a range of oncological malignancies and neurological diseases; medical preparations for the treatment of a range of oncological malignancies and neurological diseases
Class 42
Scientific servicesscientific research in the field of oncology and neurological diseases; research and development services in the field of oncology and neurological diseases; laboratory research in the field of oncology and neurological diseases; clinical research in the field of oncology and neurological diseases; scientific research in the nature of conducting clinical trials for others.
Publications
History of USPTO decisions and trademark events.
19 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/14/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/14/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/24/2026
PUBO
PUBLISHED FOR OPPOSITION
02/24/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/18/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/28/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/23/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/22/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/22/2026
RFNT
REFUSAL PROCESSED BY IB
10/03/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/17/2025
RFRR
REFUSAL PROCESSED BY MPU
09/17/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/08/2025
CNRT
NON-FINAL ACTION WRITTEN
08/07/2025
DOCK
ASSIGNED TO EXAMINER
07/29/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/25/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/25/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/17/2025
Continuous trademark protection
Get notified about every new filing that threatens PATHIOS THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.